Infraspace is a new cloud-based platform for early-stage infrastructure planning and design. Save time. Lower costs. Reduce environmental impact. We focus on the early stage planning and design of the projects. That's when changes have the biggest impact on costs, quality, and sustainability. Infraspace is a new platform to empower teams to make better decisions based on data and analyses. ✅Optimization algorithms ✅Cost and CO2 estimates ✅Environmental analyses

Revolusjonen er i gang! Verden endrer seg i et forrykende tempo. Innovasjon og stadig fornyelse er viktigere enn noen gang for å beholde kundene. Moderne teknologi har raskere enn noensinne gjort at IT flytter seg nærmere forretning. Nå må beslutninger tas raskt og «fail fast» er nøkkelord. Revolusjonen har såvidt begynt og i Aboveit forstår vi effekten, virkemidlene og veien til målet.   Aboveit bygger broen mellom teknologi og forretning  - Ved å ta i bruk skyens kapabiliteter hjelper vi deg med å realisere forretningsverdi og å skape fortrinn i markedet. Vi er sikre på at morgendagens vinnere er de som får mest ut av plattformene og tjenestene i skyen. Vår tilnærming til transformasjon og digitalisering vil endre måten våre kunder tenker på sky. Vi er klare for reisen og til å løfte våre kunder til nye høyder. Velkommen til Aboveit - Vi kan hjelpe deg!

Biim is a global medical company developing low-cost portable and pocketable ultrasound devices that connect to IOS and Android interfaces. Biim is entering the commercial stage with both FDA and CE approvals in place. The company has signed a 3-year distr. agreement with AngioDynamics worth a minimum of 20 million USD. Year-to-date revenue has exceeded more than 2.4 million USD. The company has secured a credit facility of 4 million USD with DNB. Biim is raising up to 9 million USD for the development of two new probes and to expand the global footprint to more than 30 countries.

OncoImmunity is a bioinformatics company providing unique machine-learning software to identify tumor-specific mutations that can be targeted by a patient’s own immune system (known as neoantigens). The OncoImmunity solution is important because recent breakthroughs in the field of Immuno-Oncology (I-O) such as the development of checkpoint inhibitors and personalized cancer vaccines, clearly demonstrate that a patient’s immune system can be harnessed to successfully treat cancer. The cost of identifying tumor-specific mutations in a patient’s cancer using next-generation sequencing (NGS) is now trivial and this technology will be key to enabling truly personalized immunotherapies to be developed in a technically and economically feasible manner. However, the remaining challenge that currently limits the field, and which is addressed by the OncoImmunity solution, is predicting which tumor-specific mutations can stimulate a patient’s immune system i.e. are immunogenic. Using NGS data as input, the OncoImmunity software enables accurate patient selection for cancer immunotherapy and can identify optimal targets for personalized cancer vaccines & cell therapies in a clinically actionable time frame. Beginning from this first product offering, OncoImmunity has the vision to become the world’s leading provider of software to guide cancer immunotherapy to improve survival rates for cancer patients. To achieve this OncoImmunity has assembled a growing team of world-class bioinformaticians, data scientists, and software engineers; developing its cutting-edge machine-learning technology that will help fulfill the promise of immunotherapy in the fight against cancer. OncoImmunity’s technology will disrupt the I-O field by offering regulatory-compliant prediction software on a software-as-a-service basis (SaaS). This will allow big pharma, biotechnology, and immunotherapy companies of any size to access OncoImmunity’s cutting-edge prediction software. The company is headquartered in an ideal scientific and entrepreneurial ecosystem to develop its technology at the Oslo Cancer Cluster Incubator; adjacent to the Institute for Cancer Research and the Norwegian Radium Hospital. OncoImmunity is a privately held company, founded in 2014 by experienced bioinformatics scientists (Dr. Trevor Clancy and Professor Eivind Hovig), and an experienced immunologist with a business development background (Dr. Richard Stratford). The company is backed by private financing from the Norwegian Radium Hospital Research Foundation, the Norwegian Cancer Society, STARTUPLAB, and Grotmol Solutions, in addition to a number of private software investors. The company is also supported by grants awarded from the Norwegian Research Council, Innovation Norway, and the EU. The company has already established both national and international collaborations and pilot projects to develop further proof-of-concept data and validate its software.

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.

A specialist travel company focusing on tours and voyages to the Nordic & Arctic regions, Scandinavia, Greenland, Iceland, Russia, Mongolia and the Baltics, with offices in Norway and Australia. 50 Degrees North is a niche, independently owned, specialist travel company that aims to give you a little more than just a holiday. We specialise regionally, as we believe it is not possible to be good at everything. We also focus on offering the most enriching style of travel. Not necessarily cheap, but rewarding, full of real-life experiences and with incredible value for money. If you are just as excited about Nordic and Arctic travel as we are, join our fast-growing international team here in Norway!

NORIGIN MEDIA is a TV Everywhere company, which enables multi-screen and OTT services for carriers, broadcasters, and content owners. The Scandinavian company offers a complete multi-screen application suite and a Live TV hosting headend capacity as primary products. NORIGIN MEDIA is reinventing how people watch TV. Join the technical revolution on how people will consume TV content in the years to come. You will architect and develop user experiences that will reach millions of TV users on Smartphones, Tablets, PCs, Connected TV, and Game Consoles.

SKILLUP focus on the larger private international training organisations that conduct training courses for first responders, paramedics and trauma teams. Skillup believes that VR technology is the key to democratize learning. By removing the dependency on everything physical, training providers are empowered with greater freedom, flexibility and control in the development, delivery and management of medical training for saving lives. SKILLUP is committed to UN Sustainability Goal No3 and No4 to help strengthen global health emergency preparedness and sustainable life-long learning for everyone.

Hybel is bringing reputability and automation to the private residential tenancy management market by providing a marketplace to match prospective tenants with landlords, as well as automating the day-to-day tasks of property management. We think there are too many bad-actors within the private residential rental market and are providing a platform where tenants & landlords can have successful tenancies and facilitate understanding their rights, responsibilities and obligations.

Norske håndlagde chilisauser Chili og kjærlighet er de to viktigste ingrediensene i våre sauser. Gründeren av Sterk Saus® heter Asle Schau-Hvatum og er en opprinnelig sørlending som har bosatt seg på det sentrale østlandet. I flere år før firmaet ble opprettet lagde Asle chilisaus hjemme for å gjøre fredagstacoen litt hottere og mer spenstig. Familie, venner og kjente smakte og ga tilbakemeldinger – slik at sausen hele tiden ble videreutviklet. Sterk Saus® har et brennhett forhold til chili – faktisk like heftig som varmeeksplosjonen du får av en modig, munnfull chilisaus. Vi elsker at smaksløkene våre blir utfordret og strukket. Og apropos løk, så er chili et voksende segment, akkurat som hvitløk var på 70/80-tallet. Kun råvarer av ypperste kvalitet blir med i våre sauskjeler. Chilimagien skjer i våre moderne produksjonslokaler i Halden, hvor vi tilbereder, koker og tapper hver eneste chiliflaske for hånd. Våre to viktigste ingredienser i sausen er chili og kjærlighet til faget. Dette kombinerer vi med moderne produksjonsmetoder, som sikrer kvalitet i alle ledd.

Songpark shall be the "Worldwide preferred solution for online musical collaboration!" Songpark is an Oslo-based company founded in 2018 by musician and computer technician Christian Ruud. The company has grown fast and is now the "most promising creative-tech startup in Norway". Musicians and investors all believe in our vision: To create an online musical community and to make it possible to play together at a distance. We are developing a solution (HW+SW) enabling musicians to play together online in real time at disparate locations. Our solution has been tested between different locations for up to 500 km. – and it works!

Vilje Bionics is a fast-growing medical exoskeleton startup based in Oslo, Norway. Our mission is to improve the lives of people with arm and hand disabilities by providing them with innovative, high-quality exoskeletons that can enhance their mobility and independence. We are a passionate team that is committed to making a positive impact on people's lives.

Frivind AS er et selskap med mange store nasjonale kunder, men vi ser fremdeles på oss selv om et gründerselskap, hvor innovativ tankegang, nysgjerrighet og problemløsning er i hovedfokus. Vi er et spennende selskap med få ansatte, men med våre smarte datamodeller er vi en seriøst aktør i vårt marked. Frivind AS utarbeider prognoser på hvordan alt fra værforhold, Covid-19, cruiseanløp og fotballkamper på stadion påvirker forbrukeratferd. Våre datamodeller finner dype sammenhenger i milliarder av data, for å beregne hvilke varer en kunde vil kjøpe eller en butikk vil selge.

Advokatguiden is an online guide to help you find a lawyer fitting your needs. We list the best lawyers in Norway and allow users to review them, to guarantee a better transparence and make it easier for users to choose the right lawyer. We offer the possibility for lawyers to claim their profile on our platform, to ensure a complete control over the communication and the information they want to show to clients. Lawyers can be contacted directly through the platform, in all privacy and for free.

Building the new standard for measuring programming skills, to give every developer who loves to write great code a seat at the table. We offer a platform of skill analysis where developers can validate coding skills in a relevant and realistic manner, with access to tools needed and with objective scores.